Literature DB >> 24048080

Gender and survival in cystic fibrosis.

Kieran McIntyre1.   

Abstract

PURPOSE OF REVIEW: Survival for patients with cystic fibrosis (CF) continues to improve. The proportion of CF patients over the age of 18 years is nearly 50%, and care providers will need to better understand this patient population. Despite these improvements, young females continue to have a worse prognosis and lower median survival compared with their male counterparts. Contributing factors to the difference in survival remain uncertain. RECENT
FINDINGS: The 'gender gap' remains an area of controversy. Recent data suggest that it still exists, though exact reasons remain unclear. For those patients diagnosed in adulthood, outcomes are also improving. Some evidence suggests persistence of the gender gap. Other data suggest a reversal of this effect. Additional work and study are needed.
SUMMARY: This review finds supporting evidence for persistence of the gender gap and outlines the effect of age and sex on survival in CF. The majority of patients with CF will now be adults; thus, care providers must be aware of the impact this will have on ongoing patient management.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24048080     DOI: 10.1097/MCP.0b013e328365af49

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  3 in total

1.  Plasma microRNA levels in male and female children with cystic fibrosis.

Authors:  C Mooney; P J McKiernan; R Raoof; D C Henshall; B Linnane; P McNally; A M A Glasgow; C M Greene
Journal:  Sci Rep       Date:  2020-01-24       Impact factor: 4.379

Review 2.  Gender differences in bronchiectasis: a real issue?

Authors:  Celine Vidaillac; Valerie F L Yong; Tavleen K Jaggi; Min-Min Soh; Sanjay H Chotirmall
Journal:  Breathe (Sheff)       Date:  2018-06

3.  Explaining the Sex Effect on Survival in Cystic Fibrosis: a Joint Modeling Study of UK Registry Data.

Authors:  David Taylor-Robinson; Daniela K Schlüter; Peter J Diggle; Jessica K Barrett
Journal:  Epidemiology       Date:  2020-11       Impact factor: 4.860

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.